Patient Note — 267838

progress_notes_267838_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID267838 (PHI redacted)
Age / Gender63 / Female
Date of Service2026-04-15
ProviderNone
FacilityPOTOMAC UROLOGY CENTER - Alexandria
PayerSentara Health Plans
Reason1. Right Stent

Diagnoses

N20.0 Calculus of kidney

Procedures (S/P History)

right ureteral stent placement on 2026-04-11

Medications

Biktarvy(Bictegravir-Emtricitab-Tenofov) 50-200-25 MG Tablet TAKE 1 TABLET BY MOUTH DAILY Oral metFORMIN HCl Gabapentin Rosuvastatin Calcium Cefuroxime Axetil Meloxicam oxyBUTYnin Chloride Progress Note: ALEC M DODD 04/15/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/21/2026 04:40 AM EDT 1/3 4/21/26, 1:40 AM Print Preview [PATIENT_NAME] DOB: [DOB] (63 yo F) Acc No. [ACCOUNT_ID] DOS: 04/15/2026 Medication List reviewed and reconciled with the patient

Past Medical History

  • HIV
  • type II diabetes
  • Degenrative arthiritis
  • Disconisia

Vitals

RR 16.0
BMI 32.55
WEIGHT 240 lbs
HEIGHT_IN 72.0

Clinical Summary (HPI)

Kidney Stone: 63yF presents in consultation for urinary stone disease. This is not the patient's 1st stone episode. She is s/p left URS/LL w/ stent (Dec. 2024). She presented to Inova ER on 4/10/[ADDRESS] A/P showed multiple right ureteral calculi in tandem in the right proximal to mid right ureter measuring up to 6mm and associated moderate right hydroureteronephrosis. UCx was positive for E. coli. Pt was admitted for septic kidney stone. Right ureteral stent was placed on 4/11/2026. Pt is here to discuss definitive stone management. She is currently on Ceftin. No acute concerns today. ------------ The patient's previous work-up history is listed below: Current Medical Therapy: tamsulosin; oxybutynin. Cr: 1.1 (4/10/26). Stone composition: n/a. Urine pH: 6.5 (4/10/26). Calcium: 9.3 (4/10/26). CT A/P (4/10/26): Impression - 1) Multiple calculi visualized in tandem within the proximal to mid right ureter measuring up to 6mm contributing to moderate right-sided hydroureteronephrosis. 2) Multiple nonobstructing right renal calculi identified measuring up to 4mm. 3) Hepatic steatosis. 4) Cholelithiasis. Renal US: n/a. KUB: n/a. 24 Hour Urine: n/a. Prior Surgery: Left URS/LL w/ stent (Dec. 2024). UCx: >100,000 CFU/ml E. coli (4/10/26).

Raw Note (de-identified preview)

4/21/26, 1:40 AM Print Preview [PATIENT_NAME] DOB: [DOB] (63 yo F) Acc No. [ACCOUNT_ID] DOS: 04/15/2026 [PATIENT_NAME] 63 Y old Female, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] [ADDRESS] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Sentara Health Plans (FNA Optima) PCP: Chad Zik Referring: Chad Zik Appointment Facility: POTOMAC UROLOGY CENTER - Alexandria 04/15/2026 Progress Notes: ALEC M DODD Reason for Appointment 1. Right Stent History of Present Illness Kidney Stone: 63yF presents in consultation for urinary stone disease. This is not the patient's 1st stone episode. She is s/p left URS/LL w/ stent (Dec. 2024). She presented to Inova ER on 4/10/[ADDRESS] A/P showed multiple right ureteral calculi in tandem in the right proximal to mid right ureter measuring up to 6mm and associated moderate right hydroureteronephrosis. UCx was positive for E. coli. Pt was admitted for septic kidney stone. Right ureteral stent was placed on 4/11/2026. Pt is here to discuss definitive stone management. She is currently on Ceftin. No acute concerns today. ------------ The patient's previous work-up history is listed below: Current Medical Therapy: tamsulosin; oxybutynin. Cr: 1.1 (4/10/26). Stone composition: n/a. Urine pH: 6.5 (4/10/26). Calcium: 9.3 (4/10/26). CT A/P (4/10/26): Impression - 1) Multiple calculi visualized in tandem within the proximal to mid right ureter measuring up to 6mm contributing to moderate right-sided hydroureteronephrosis. 2) Multiple nonobstructing right renal calculi identified measuring up to 4mm. 3) Hepatic steatosis. 4) Cholelithiasis. Renal US: n/a. KUB: n/a. 24 Hour Urine: n/a. Prior Surgery: Left URS/LL w/ stent (Dec. 2024). UCx: >100,000 CFU/ml E. coli (4/10/26). Current Medications Taking Biktarvy(Bictegravir-Emtricitab-Tenofov) 50-200-25 MG Tablet TAKE 1 TABLET BY MOUTH DAILY Oral metFORMIN HCl 850 MG Tablet Oral Gabapentin 600 MG Tablet Oral Rosuvastatin Calcium 10 MG Tablet Oral Cefuroxime Axetil 250 MG Tablet Oral Meloxicam 15 MG Tablet Oral oxyBUTYnin Chloride 5 MG Tablet Oral Progress Note: ALEC M DODD 04/15/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/21/2026 04:40 AM EDT 1/3 4/21/26, 1:40 AM Print Preview [PATIENT_NAME] DOB: [DOB] (63 yo F) Acc No. [ACCOUNT_ID] DOS: 04/15/2026 Medication List reviewed and reconciled with the patient Past Medical History HIV. type II diabetes. Degenrative arthiritis. Disconisia. Surgical History kidney stone removal c section Family History Father: deceased Mother: alive Social History Smoking: no Recreational drug use: no. Exercise: yes. Caffeine: no. Sexually active: no. Occupation: yes, Retired. Screening Allergies N.K.D.A. Hospitalization/Major Diagnostic Procedure kidney stones/inova 4/11/2026 Review of Systems 12 system Review of Systems completed in the chart and all pertinent positives and negatives reviewed with the patient...ee. Vital Signs RR: 16, HR: Not Taken - Collection Device